|
Volumn 353, Issue 24, 2005, Pages 2535-2537
|
Influenza - Interpandemic as well as pandemic disease
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMANTADINE;
INFLUENZA VACCINE;
LIVE VACCINE;
OSELTAMIVIR;
RIMANTADINE;
SIALIDASE INHIBITOR;
ZANAMIVIR;
CAUSE OF DEATH;
DISEASE TRANSMISSION;
ENDEMIC DISEASE;
EPIDEMIC;
HIGH RISK BEHAVIOR;
HUMAN;
INFECTION CONTROL;
INFLUENZA;
INFLUENZA VIRUS;
PATHOGENESIS;
PRIORITY JOURNAL;
SHORT SURVEY;
VACCINATION;
VIRUS VIRULENCE;
ADOLESCENT;
ADULT;
AGE DISTRIBUTION;
AGED;
AGED, 80 AND OVER;
ANTIVIRAL AGENTS;
CHILD;
CHILD, PRESCHOOL;
DISEASE OUTBREAKS;
FEMALE;
HOSPITALIZATION;
HUMANS;
INFANT;
INFLUENZA A VIRUS, H1N1 SUBTYPE;
INFLUENZA A VIRUS, H5N1 SUBTYPE;
INFLUENZA VACCINES;
INFLUENZA, HUMAN;
PREGNANCY;
SENTINEL SURVEILLANCE;
UNITED STATES;
|
EID: 28944453791
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMp058276 Document Type: Short Survey |
Times cited : (16)
|
References (6)
|